The United States owns the patent for the Cure For - TopicsExpress



          

The United States owns the patent for the Cure For A.I.D.S. This is just part of it. United States Patent5,676,977AntelmanOctober 14, 1997Method of curing AIDS with tetrasilver tetroxide molecular crystal devices Abstract The diamagnetic semiconducting molecular crystal tetrasilver tetroxide (Ag.sub.4 O.sub.4) is utilized for destroying the AIDS virus, destroying AIDS synergistic pathogens and immunity suppressing moieties (ISM) in humans. A single intravenous injection of the devices is all that is required for efficacy at levels of about 40 PPM of human blood. The device molecular crystal contains two mono and two trivalent silver ions capable of firing electrons capable of electrocuting the AIDS virus, pathogens and ISM. When administered into the bloodstream, the device electrons will be triggered by pathogens, a proliferating virus and ISM, and when fired will simultaneously trigger a redox chelation mechanism resulting in divalent silver moieties which chelate and bind active sites of the entities destroying them. The devices are completely non-toxic. However, they put stress on the liver causing hepatomegaly, but there is no loss of liver function. Inventors:Antelman; Marvin S. (Rehovot, IL)Assignee:Antelman Technologies Ltd. (Providence, RI) Family ID:24643433Appl. No.:08/658,955Filed:May 31, 1996Related U.S. Patent DocumentsApplication NumberFiling DatePatent NumberIssue Date310859Sep 22, 1994 Current U.S. Class:424/618 ; 514/495Current CPC Class:A61K 33/38 (20130101)Current International Class:A61K 33/38 (20060101); A61K 033/38 ()Field of Search:;424/618 ;514/495 References Cited [Referenced By]U.S. Patent Documents4415565November 1983Wysor4915955April 1990Gomori4952411August 1990Fox, Jr. et al.5073382December 1991Antelman5078902January 1992Antelman5089275February 1992Antelman5211855May 1993Antelman5223149June 1993Antelman5336499August 1994Antelman5571520November 1996Antelman Other References Is The AIDS Virus A Science Fiction? by Peter H. Duesberg and Bryan J. Ellison, Policy Review, Summer 1990, pp. 40-51.. Primary Examiner: Hulina; Amy Attorney, Agent or Firm: Salter & Michaelson Parent Case Text This application is a continuation-in-part of patent application Ser. No. 08/310,859 filed Sep. 22, 1994, now abandoned.Claims What is claimed is: 1. A method of treating AIDS-afflicted humans comprising injecting a multitude of tetrasilver tetroxide molecular crystals into the bloodstream of the human subject. 2. A method for increasing white blood cell counts in AIDS-afflicted humans comprising injecting a multitude of tetrasilver tetroxide molecular crystals into the bloodstream of the human subject. 3. Methods of treating AIDS-affilicted humans according to claims 1-2 where the concentration of said molecular crystals is approximately 40 PPM of the total blood weight of the human subject.
Posted on: Sat, 11 Oct 2014 22:04:35 +0000

Trending Topics



Recently Viewed Topics




© 2015